193 related articles for article (PubMed ID: 10333478)
21. Contribution of superoxide to reduced antioxidant activity of glycoxidative serum albumin.
Sakata N; Moh A; Takebayashi S
Heart Vessels; 2002 Nov; 17(1):22-9. PubMed ID: 12434198
[TBL] [Abstract][Full Text] [Related]
22. The mechanism of kinetic inhibition of Cu(II)-induced oxidation of low density lipoprotein by lanthanide ions.
Liu H; Cheng Y; Lu J; Li R; Wang K
J Inorg Biochem; 2006 Jul; 100(7):1280-9. PubMed ID: 16678267
[TBL] [Abstract][Full Text] [Related]
23. Probabilistic kinetic model of slow oxidation of low-density lipoprotein: II. Experiments.
Krilov D; Stojanović N; Herak JN
Chem Phys Lipids; 2004 Apr; 129(1):75-84. PubMed ID: 14998729
[TBL] [Abstract][Full Text] [Related]
24. Comparison of LDL fatty acid and carotenoid concentrations and oxidative resistance of LDL in volunteers from countries with different rates of cardiovascular disease.
Wright AJ; Southon S; Chopra M; Meyer-Wenger A; Moser U; Granado F; Olmedilla B; Corridan B; Hinninger I; Roussel AM; van den Berg H; Thurnham DI
Br J Nutr; 2002 Jan; 87(1):21-9. PubMed ID: 11898767
[TBL] [Abstract][Full Text] [Related]
25. Effect of caffeine on oxidation susceptibility of human plasma low density lipoproteins.
Krisko A; Kveder M; Pifat G
Clin Chim Acta; 2005 May; 355(1-2):47-53. PubMed ID: 15820477
[TBL] [Abstract][Full Text] [Related]
26. Aluminum ions stimulate the oxidizability of low density lipoprotein by Fe2+: implication in hemodialysis mediated atherogenic LDL modification.
Kapiotis S; Hermann M; Exner M; Sturm BN; Scheiber-Mojdehkar B; Goldenberg H; Kopp S; Chiba P; Gmeiner BM
Free Radic Res; 2005 Nov; 39(11):1225-31. PubMed ID: 16298749
[TBL] [Abstract][Full Text] [Related]
27. Redox cycles of caffeic acid, alpha-tocopherol, and ascorbate: implications for protection of low-density lipoproteins against oxidation.
Laranjinha J; Cadenas E
IUBMB Life; 1999 Jul; 48(1):57-65. PubMed ID: 10791916
[TBL] [Abstract][Full Text] [Related]
28. [Effects of alpha-tocopherol and beta-carotene on the oxidized low density lipoprotein induced by Cu2+].
Cheng X; Cui Y; Chen Y; Zhang X
Wei Sheng Yan Jiu; 2000 Jul; 29(4):229-31. PubMed ID: 12520927
[TBL] [Abstract][Full Text] [Related]
29. [Inhibition effect of soybean isoflavones on the oxidative modification of low-density lipoprotein].
Yan X; Gu J; Sun C; Liu D
Wei Sheng Yan Jiu; 2001 Nov; 30(6):346-9. PubMed ID: 12561616
[TBL] [Abstract][Full Text] [Related]
30. Reversible reduction of phospholipid bound arachidonic acid after low density lipoprotein apheresis. Evidence for rapid incorporation of plasmalogen phosphatidylethanolamine into the red blood cell membrane.
Engelmann B; Bräutigam C; Kulschar R; Duhm J; Prenner E; Hermetter A; Richter WO; Thiery J; Seidel D
Biochim Biophys Acta; 1994 Dec; 1196(2):154-64. PubMed ID: 7841179
[TBL] [Abstract][Full Text] [Related]
31. HDL enhances oxidation of LDL in vitro in both men and women.
Solakivi T; Jaakkola O; Salomäki A; Peltonen N; Metso S; Lehtimäki T; Jokela H; Nikkari ST
Lipids Health Dis; 2005 Oct; 4():25. PubMed ID: 16242018
[TBL] [Abstract][Full Text] [Related]
32. Composition of plasmalogens in serum lipoproteins from patients with non-alcoholic steatohepatitis and their susceptibility to oxidation.
Ikuta A; Sakurai T; Nishimukai M; Takahashi Y; Nagasaka A; Hui SP; Hara H; Chiba H
Clin Chim Acta; 2019 Jun; 493():1-7. PubMed ID: 30796899
[TBL] [Abstract][Full Text] [Related]
33. Plasmalogens in biological systems: their role in oxidative processes in biological membranes, their contribution to pathological processes and aging and plasmalogen analysis.
Lessig J; Fuchs B
Curr Med Chem; 2009; 16(16):2021-41. PubMed ID: 19519379
[TBL] [Abstract][Full Text] [Related]
34. Oxidation of fluorescent glycero- and sphingophospholipids in human plasma lipoproteins: alkenylacyl subclasses are preferred targets.
Hofer G; Lichtenberg D; Kostner GM; Hermetter A
Clin Biochem; 1996 Oct; 29(5):445-50. PubMed ID: 8884065
[TBL] [Abstract][Full Text] [Related]
35. Oral bioavailability of the ether lipid plasmalogen precursor, PPI-1011, in the rabbit: a new therapeutic strategy for Alzheimer's disease.
Wood PL; Smith T; Lane N; Khan MA; Ehrmantraut G; Goodenowe DB
Lipids Health Dis; 2011 Dec; 10():227. PubMed ID: 22142382
[TBL] [Abstract][Full Text] [Related]
36. Functions of plasmalogen lipids in health and disease.
Braverman NE; Moser AB
Biochim Biophys Acta; 2012 Sep; 1822(9):1442-52. PubMed ID: 22627108
[TBL] [Abstract][Full Text] [Related]
37. Interaction of plasmenylcholine with free radicals in selected model systems.
Broniec A; Żądło A; Pawlak A; Fuchs B; Kłosiński R; Thompson D; Sarna T
Free Radic Biol Med; 2017 May; 106():368-378. PubMed ID: 28232206
[TBL] [Abstract][Full Text] [Related]
38. Decreased plasmalogen ratios in cultured skin fibroblasts from myotonic dystrophy.
Sakai T; Antoku Y
Muscle Nerve; 1987 Sep; 10(7):626-8. PubMed ID: 3657848
[TBL] [Abstract][Full Text] [Related]
39. Mouse brain plasmalogens are targets for hypochlorous acid-mediated modification in vitro and in vivo.
Ullen A; Fauler G; Köfeler H; Waltl S; Nusshold C; Bernhart E; Reicher H; Leis HJ; Wintersperger A; Malle E; Sattler W
Free Radic Biol Med; 2010 Dec; 49(11):1655-65. PubMed ID: 20807565
[TBL] [Abstract][Full Text] [Related]
40. Identification of plasmalogen in the gut of silkworm (Bombyx mori).
Aboshi T; Nishida R; Mori N
Insect Biochem Mol Biol; 2012 Aug; 42(8):596-601. PubMed ID: 22580185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
